Influenza Insights: When Flu Strikes Patients With Rheumatic Diseases is organized by Vindico Medical Education.

This enduring material is approved for 1 year from the date of original release, February 28, 2021 to February 27, 2022.

Target Audience:
The intended audience for this activity is internists, rheumatologists, nurse practitioners, physician assistants, and other health care professionals involved in the management of patients with influenza.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.33 hours of pharmacology) by the American Association of Nurse Practitioners. Activity ID 21024751. This activity was planned in accordance with AANP Accreditation Standards and Policies.

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 2/28/2021 to 2/27/2022. PAs should only claim credit commensurate with the extent of their participation. AAPA reference number: CME-202202.

Activity Description:
Influenza places a substantial burden on the health of both children and adults in the United States each year. Although immunization helps to prevent flu infection, there is a need for improved diagnostics, treatments, and preventative measures, especially in high-risk patients who have comorbid illnesses or who are immunocompromised. Patients with rheumatic disorders are particularly vulnerable to infections because of abnormalities in their immune system and the immunosuppressive effects of the medications. Therefore, it is important that rheumatologists and internists are competent in their management of patients who have a rheumatic disease and are either exposed to or contract influenza, especially during the COVID-19 pandemic. In this continuing educational activity, expert clinicians will discuss the latest updates on diagnosing and treating influenza.

Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Assess the burden of influenza in patients at high risk for complications.
• Apply knowledge of evidence-based guidelines and algorithms when interpreting the results of tests that detect influenza in immunocompromised patients.
• Assess clinical findings in use of influenza treatment in immunocompromised patients based on evidence of the regimen’s safety and efficacy in these patients.


PhysicianPharmacistPhysician Assistant


RheumatologyInfectious Disease


COVID-19 and Seasonal Flu 2022-2023: What Healthcare Professionals Need to Know
Oct 06, 2022 - Oct 02, 2023 | Text-Based CME
Infectious Disease
2 Contact Hours
More actions
Rheumatoid Arthritis and Cardiovascular Risk Considerations
Sep 16, 2022 - Sep 16, 2025 | Text-Based CME
State required course for Alaska ...
1 Contact Hours
More actions
128: Malaria Surveillance (N)

128: Malaria Surveillance (N)

By Medical Education Systems...
May 01, 2022 - May 31, 2023 | Text-Based CME
5 CEUs
More actions